MARVELON Side Effects

6285902-6 | Anxiety, Choking Sensation, Menstruation Irregular, Metrorrhagia, Reflux Oesophagitis, Stress
on Jul 13, 2009 Female patient from JAPAN , 48 years of age, was treated with Marvelon (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), choking sensation, menstruation irregular, metrorrhagia, reflux oesophagitis, stress (What is stress?). Marvelon dosage: Df;. During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), CLOTIAZEPAM (View Clotiazepam Review and Clotiazepam Label ).

6275813-4 | Cardiac Arrest, Hypoxic Encephalopathy, Off Label Use, Pulmonary Embolism
Patient was taking Marvelon (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), hypoxic encephalopathy, off label use, pulmonary embolism (What is pulmonary embolism?) on Jul 10, 2009 from JAPAN Additional patient health information: Female patient , 34 years of age, was diagnosed with dysmenorrhoea, menstruation irregular, premenstrual syndrome (What is premenstrual syndrome?) and. Marvelon dosage: 1 Df, Oral. During the same period patient was treated with GENTAMICIN SULFATE (View Gentamicin Sulfate Review and Gentamicin Sulfate Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

6265354-2 | Cardiac Arrest, Hypoxic Encephalopathy, Pulmonary Embolism, Respiratory Arrest
Adverse event was reported on Jun 30, 2009 by a Female patient taking Marvelon (View Usage) (Dosage: 1 Df Oral) was diagnosed with dysmenorrhoea, menstruation irregular, premenstrual syndrome (What is premenstrual syndrome?) and. Location: JAPAN , 34 years of age, After Marvelon was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), hypoxic encephalopathy, pulmonary embolism (What is pulmonary embolism?), respiratory arrest.

6170888-5 | Arterial Thrombosis Limb, Myofascitis
on Apr 15, 2009 Female patient from JAPAN , 32 years of age, was diagnosed with contraception and was treated with Marvelon (View Usage). Patient experienced the following unwanted or unexpected effects: arterial thrombosis limb, myofascitis. Marvelon dosage: Df Oral. Patient was hospitalized.


6170887-3 | Myositis, Thrombophlebitis
on Apr 14, 2008 Female patient from JAPAN , 32 years of age, was diagnosed with contraception and was treated with Marvelon (View Usage). Patient had the following side effects: myositis (What is myositis?), thrombophlebitis. Marvelon dosage: Df Oral. Patient was hospitalized.

6159292-3 | Arteriovenous Fistula, Blood Human Chorionic Gonadotropin Abnormal, Endometrial Disorder, Pregnancy, Treatment Noncompliance, Uterine Haemorrhage
Patient was taking Marvelon (View Usage). After Marvelon was administered, patient had the following side effects: arteriovenous fistula, blood human chorionic gonadotropin abnormal, endometrial disorder, pregnancy (What is pregnancy?), treatment noncompliance, uterine haemorrhage on Apr 03, 2009 from CHINA Additional patient health information: Female patient , 31 years of age, was diagnosed with contraception and. Marvelon dosage: 1 Df Oral. Patient was hospitalized.

6157815-1 | Fall, Pulmonary Embolism
Adverse event was reported on Apr 07, 2009 by a Female patient taking Marvelon (View Usage) (Dosage: 1 Df Oral) was diagnosed with dysmenorrhoea, endometriosis (What is endometriosis?) and. Location: JAPAN , 38 years of age, Patient experienced the following unwanted or unexpected effects: fall (What is fall?), pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with LUNABELL (Df Oral) (View Lunabell Review and Lunabell Label ).

6154289-1 | Fall, Mental Disorder, Pulmonary Embolism
on Apr 01, 2009 Female patient from JAPAN , 38 years of age, was diagnosed with dysmenorrhoea, endometriosis (What is endometriosis?) and was treated with Marvelon (View Usage). Patient had the following side effects: fall (What is fall?), mental disorder, pulmonary embolism (What is pulmonary embolism?). Marvelon dosage: 1 Df, Oral.

6147517-X | Fall, Mental Disorder, Pulmonary Embolism
on Mar 27, 2009 Female patient from JAPAN , 38 years of age, was diagnosed with endometriosis (What is endometriosis?) and was treated with Marvelon (View Usage). After Marvelon was administered, patient had the following side effects: fall (What is fall?), mental disorder, pulmonary embolism (What is pulmonary embolism?). Marvelon dosage: Df Oral. During the same period patient was treated with NORETHISTERONE W/ESTROGENS (View Norethisterone W/estrogens Review and Norethisterone W/estrogens Label ).

6134757-9 | Abdominal Pain Upper, Diabetes Mellitus, Hypercoagulation, Hyperlipidaemia, Inflammation, Nasopharyngitis, Portal Vein Thrombosis
Patient was taking Marvelon (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, diabetes mellitus, hypercoagulation, hyperlipidaemia, inflammation, nasopharyngitis, portal vein thrombosis on Mar 11, 2009 from JAPAN Additional patient health information: Female patient , 25 years of age, was diagnosed with polycystic ovaries and. Marvelon dosage: Df Oral. Patient was hospitalized.

6103638-9 | Anaemia, Metrorrhagia, Oedema Peripheral
Adverse event was reported on Feb 24, 2009 by a Female patient taking Marvelon (View Usage) (Dosage: 1 Df Oral) . Location: JAPAN , 38 years of age, Patient had the following side effects: anaemia, metrorrhagia, oedema peripheral. During the same period patient was treated with AMEZINIUM METILSULFATE (View Amezinium Metilsulfate Review and Amezinium Metilsulfate Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

6090899-8 | Blood Cholesterol Increased, Hypertensive Crisis
on Mar 10, 2008 Female patient from FRANCE , 39 years of age, was treated with Marvelon (View Usage). After Marvelon was administered, patient had the following side effects: blood cholesterol increased, hypertensive crisis. Marvelon dosage: Df. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ).

6060103-5 | Axillary Vein Thrombosis, Cyanosis, Subclavian Vein Thrombosis, Thrombophlebitis Superficial
on Jan 15, 2009 Female patient from FRANCE , 32 years of age, was diagnosed with contraception and was treated with Marvelon (View Usage). Patient experienced the following unwanted or unexpected effects: axillary vein thrombosis, cyanosis, subclavian vein thrombosis, thrombophlebitis superficial. Marvelon dosage: 1 Df Oral. During the same period patient was treated with SOTALOL (View Sotalol Review and Sotalol Label ). Patient was hospitalized.

6060097-2 | Axillary Vein Thrombosis, Cyanosis, Subclavian Vein Thrombosis, Thrombophlebitis Superficial
Patient was taking Marvelon (View Usage). Patient had the following side effects: axillary vein thrombosis, cyanosis, subclavian vein thrombosis, thrombophlebitis superficial on Jan 15, 2009 from FRANCE Additional patient health information: Female patient , 32 years of age, was diagnosed with contraception and. Marvelon dosage: 1 Df Oral. During the same period patient was treated with SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ). Patient was hospitalized.

6032119-6 | Anxiety, Metrorrhagia, Musculoskeletal Chest Pain, Reflux Oesophagitis
Adverse event was reported on Dec 26, 2008 by a Female patient taking Marvelon (View Usage) (Dosage: Df) . Location: JAPAN , 48 years of age, After Marvelon was administered, patient had the following side effects: anxiety (What is anxiety?), metrorrhagia, musculoskeletal chest pain, reflux oesophagitis. During the same period patient was treated with PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), CLOTIAZEPAM (View Clotiazepam Review and Clotiazepam Label ).

6029112-6 | Hypoaesthesia, Muscular Weakness
on Dec 17, 2008 Female patient from UNITED KINGDOM , 29 years of age, was diagnosed with contraception and was treated with Marvelon (View Usage). Patient experienced the following unwanted or unexpected effects: hypoaesthesia, muscular weakness. Marvelon dosage: 1 Df Oral.

6003031-3 | Prolactinoma
on Dec 03, 2008 Female patient from NORWAY , 17 years of age, was diagnosed with contraception and was treated with Marvelon (View Usage). Patient had the following side effects: prolactinoma. Marvelon dosage: Df.

5926131-2 | Hyperhidrosis, Mental Disorder, Metrorrhagia, Palpitations
Patient was taking Marvelon (View Usage). After Marvelon was administered, patient had the following side effects: hyperhidrosis, mental disorder, metrorrhagia, palpitations on Oct 07, 2008 from JAPAN Additional patient health information: Female patient , 23 years of age, . Marvelon dosage: Df.

5848461-5 | Feeling Abnormal, Headache, Speech Disorder
Adverse event was reported on Jul 31, 2008 by a Female patient taking Marvelon (View Usage) (Dosage: 1 Df Oral) . Location: JAPAN , 44 years of age, Patient experienced the following unwanted or unexpected effects: feeling abnormal, headache (What is headache?), speech disorder.

5778151-9 | Anaemia, Antiphospholipid Antibodies, Chest Discomfort, Choking, Dyspnoea, Hypoaesthesia, Palpitations, Thrombosis
on Jun 03, 2008 Female patient from UNITED STATES , 38 years of age, weighting 132.3 lb, was diagnosed with contraception and was treated with Marvelon (View Usage). Patient had the following side effects: anaemia, antiphospholipid antibodies, chest discomfort, choking (What is choking?), dyspnoea, hypoaesthesia, palpitations, thrombosis. Marvelon dosage: Oral.

5635752-6 | Cognitive Disorder, Encephalopathy, Visual Acuity Reduced
on Feb 08, 2008 Female patient from UNITED KINGDOM , 19 years of age, was treated with Marvelon (View Usage). After Marvelon was administered, patient had the following side effects: cognitive disorder, encephalopathy, visual acuity reduced. Marvelon dosage: Df.

5557979-4 | Transient Ischaemic Attack
Patient was taking Marvelon (View Usage). Patient experienced the following unwanted or unexpected effects: transient ischaemic attack on Nov 30, 2007 from CANADA Additional patient health information: Female patient , 29 years of age, was diagnosed with contraception and. Marvelon dosage: 1 Df Oral. Patient was hospitalized.

5518098-6 | Anaemia, Dysmenorrhoea, Uterine Leiomyoma
Adverse event was reported on Nov 01, 2007 by a Female patient taking Marvelon (View Usage) (Dosage: Df) . Location: JAPAN , 43 years of age, Patient had the following side effects: anaemia, dysmenorrhoea, uterine leiomyoma.

5458148-9 | Dysarthria, Dysphasia, Paraesthesia, Paresis, Transient Ischaemic Attack
on Sep 05, 2007 Female patient from CANADA , 29 years of age, was treated with Marvelon (View Usage). After Marvelon was administered, patient had the following side effects: dysarthria, dysphasia, paraesthesia, paresis, transient ischaemic attack. Marvelon dosage: 1 Df Oral.

5424422-5 | Anaemia, Condition Aggravated, Dysmenorrhoea, Uterine Leiomyoma
on Aug 09, 2007 Female patient from JAPAN , 43 years of age, was treated with Marvelon (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, condition aggravated, dysmenorrhoea, uterine leiomyoma. Marvelon dosage: Df.

5317828-6 | Cardiac Arrest, Cold Sweat, Cyanosis, Deep Vein Thrombosis, Dehydration, Gait Disturbance, Hypotension, Musculoskeletal Chest Pain, Palpitations
Patient was taking Marvelon (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), cold sweat, cyanosis, deep vein thrombosis (What is deep vein thrombosis?), dehydration, gait disturbance, hypotension, musculoskeletal chest pain, palpitations on Apr 24, 2007 from DENMARK Additional patient health information: Female patient , 27 years of age, was diagnosed with contraception and. Marvelon dosage: Df.

5266690-9 | Glomerulonephritis Chronic
Adverse event was reported on Feb 27, 2007 by a Female patient taking Marvelon (View Usage) (Dosage: 1 Df Oral) was diagnosed with menorrhagia and. Location: CHINA , 35 years of age, After Marvelon was administered, patient had the following side effects: glomerulonephritis chronic.

5258260-3 | Haematochezia
on Feb 19, 2007 Female patient from SWEDEN , 22 years of age, was diagnosed with contraception and was treated with Marvelon (View Usage). Patient experienced the following unwanted or unexpected effects: haematochezia. Marvelon dosage: Df.

5258232-9 | Androgens Abnormal, Cardiac Arrest, Cold Sweat, Cyanosis, Deep Vein Thrombosis, Dehydration, Hypotension, Musculoskeletal Chest Pain, Palpitations
on Feb 27, 2007 Female patient from DENMARK , 27 years of age, was diagnosed with contraception and was treated with Marvelon (View Usage). Patient had the following side effects: androgens abnormal, cardiac arrest (What is cardiac arrest?), cold sweat, cyanosis, deep vein thrombosis (What is deep vein thrombosis?), dehydration, hypotension, musculoskeletal chest pain, palpitations. Marvelon dosage: Df Ni.

5194520-2 | Pulmonary Embolism
Patient was taking Marvelon (View Usage). After Marvelon was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?) on Dec 14, 2006 from DENMARK Additional patient health information: Female patient , 27 years of age, was diagnosed with contraception and. Marvelon dosage: Df.

5139617-8 | Endocarditis, Hepatic Function Abnormal, Immunoglobulins Decreased, Mitral Valve Incompetence, Platelet Count Decreased, Staphylococcal Sepsis
Adverse event was reported on Oct 11, 2006 by a Female patient taking Marvelon (View Usage) (Dosage: Df, Oral) was diagnosed with amenorrhoea and. Location: JAPAN , 40 years of age, Patient experienced the following unwanted or unexpected effects: endocarditis (What is endocarditis?), hepatic function abnormal, immunoglobulins decreased, mitral valve incompetence, platelet count decreased, staphylococcal sepsis. During the same period patient was treated with PL (View Pl Review and Pl Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ). Patient was hospitalized.

5123342-3 | Anaphylactic Reaction, Pulmonary Embolism, Respiratory Arrest
on Sep 22, 2006 Female patient from UNITED KINGDOM , 36 years of age, was diagnosed with contraception and was treated with Marvelon (View Usage). Patient had the following side effects: anaphylactic reaction, pulmonary embolism (What is pulmonary embolism?), respiratory arrest. Marvelon dosage: Df.

5123341-1 | Anaphylactic Reaction, Pulmonary Embolism, Respiratory Arrest
on Sep 22, 2006 Female patient from UNITED KINGDOM , 36 years of age, was diagnosed with contraception and was treated with Marvelon (View Usage). After Marvelon was administered, patient had the following side effects: anaphylactic reaction, pulmonary embolism (What is pulmonary embolism?), respiratory arrest. Marvelon dosage: Df.

5122690-0 | Dizziness, Hepatic Function Abnormal, Platelet Count Decreased, White Blood Cell Count Increased
Patient was taking Marvelon (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hepatic function abnormal, platelet count decreased, white blood cell count increased on Sep 28, 2006 from JAPAN Additional patient health information: Female patient , 40 years of age, was diagnosed with premature menopause and. Marvelon dosage: Df Oral. Patient was hospitalized.

5063636-3 | Cardiomegaly, Haemoglobin Abnormal, Pulmonary Embolism, Pulmonary Oedema, Respiratory Arrest, Syncope, Upper Respiratory Tract Infection, Venous Thrombosis Limb, Vertigo
Adverse event was reported on Jul 17, 2006 by a Female patient taking Marvelon (View Usage) (Dosage: Df Oral) was diagnosed with polycystic ovaries and. Location: SWEDEN , 39 years of age, Patient had the following side effects: cardiomegaly, haemoglobin abnormal, pulmonary embolism (What is pulmonary embolism?), pulmonary oedema, respiratory arrest, syncope, upper respiratory tract infection, venous thrombosis limb, vertigo. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ).

5054063-3 | Hepatic Steatosis, Palpitations
on Jun 30, 2006 Female patient from JAPAN , 38 years of age, was diagnosed with contraception and was treated with Marvelon (View Usage). After Marvelon was administered, patient had the following side effects: hepatic steatosis, palpitations. Marvelon dosage: Df Oral.

4977384-9 | Acute Myocardial Infarction, Coronary Artery Thrombosis, Prinzmetal Angina
on Apr 06, 2006 Female patient from JAPAN , 37 years of age, was diagnosed with endometriosis (What is endometriosis?), menorrhagia and was treated with Marvelon (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, coronary artery thrombosis, prinzmetal angina. Marvelon dosage: Df. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

4976388-X | Arterial Thrombosis, Myocardial Infarction
Patient was taking Marvelon (View Usage). Patient had the following side effects: arterial thrombosis, myocardial infarction on Mar 28, 2006 from JAPAN Additional patient health information: Female patient , 37 years of age, was diagnosed with menorrhagia and. Marvelon dosage: Df Oral. During the same period patient was treated with DANAZOL (View Danazol Review and Danazol Label ). Patient was hospitalized.

4954029-5 | Activated Partial Thromboplastin Time Prolonged, Blood Fibrinogen Increased, Blood Pressure Increased, Body Temperature Decreased, Fibrin D Dimer Increased, Pleurisy, Pneumonia, Pulmonary Artery Thrombosis, Venous Thrombosis Limb
Adverse event was reported on Mar 10, 2006 by a Female patient taking Marvelon (View Usage) (Dosage: Df Oral) was diagnosed with contraception, menorrhagia and. Location: JAPAN , 45 years of age, After Marvelon was administered, patient had the following side effects: activated partial thromboplastin time prolonged, blood fibrinogen increased, blood pressure increased, body temperature decreased, fibrin d dimer increased, pleurisy, pneumonia (What is pneumonia?), pulmonary artery thrombosis, venous thrombosis limb. Patient was hospitalized.

4924653-4 | Blood Pressure Increased, Pleurisy, Pneumonia, Pulmonary Artery Thrombosis, Pulmonary Embolism, Raynaud's Phenomenon, Sjogren's Syndrome, Venous Thrombosis Limb
on Feb 10, 2006 Female patient from JAPAN , 45 years of age, was diagnosed with contraception, menorrhagia and was treated with Marvelon (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, pleurisy, pneumonia (What is pneumonia?), pulmonary artery thrombosis, pulmonary embolism (What is pulmonary embolism?), raynaud's phenomenon, sjogren's syndrome (What is sjogren's syndrome?), venous thrombosis limb. Marvelon dosage: Df Oral. Patient was hospitalized.

4924652-2 | Hepatitis Cholestatic
on Feb 08, 2006 Female patient from INDIA , 13 years of age, was diagnosed with menorrhagia and was treated with Marvelon (View Usage). Patient had the following side effects: hepatitis cholestatic. Marvelon dosage: Df Oral. During the same period patient was treated with MALARONE (View Malarone Review and Malarone Label ). Patient was hospitalized.

4924650-9 | Hepatic Failure, Hepatic Haemorrhage, Liver Disorder, Loss Of Consciousness, Lymphadenopathy, Pyrexia, Renal Failure, Respiratory Failure
Patient was taking Marvelon (View Usage). After Marvelon was administered, patient had the following side effects: hepatic failure, hepatic haemorrhage, liver disorder, loss of consciousness, lymphadenopathy, pyrexia, renal failure, respiratory failure on Feb 10, 2006 from JAPAN Additional patient health information: Female patient , 23 years of age, was diagnosed with dysmenorrhoea and. Marvelon dosage: Df Oral. During the same period patient was treated with KAKKON TO (View Kakkon-to Review and Kakkon-to Label ).

4914150-4 | Pulmonary Embolism
Adverse event was reported on Jan 24, 2006 by a Female patient taking Marvelon (View Usage) (Dosage: Df Oral) was diagnosed with contraception, menorrhagia and. Location: JAPAN , 45 years of age, Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Patient was hospitalized.

4914141-3 | Cold Sweat, Lacunar Infarction, Nausea, Panic Reaction, Stress
on Jan 31, 2006 Female patient from SWEDEN , 35 years of age, was diagnosed with obesity (What is obesity?) and was treated with Marvelon (View Usage). Patient had the following side effects: cold sweat, lacunar infarction, nausea (What is nausea?), panic reaction, stress (What is stress?). Marvelon dosage: Df. During the same period patient was treated with SIBUTRAMINE HYDROCHLORIDE (Df/15 Mg Oral) (View Sibutramine Hydrochloride Review and Sibutramine Hydrochloride Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ).

4913324-6 | Haemodialysis, Hepatic Failure, Hepatic Haemorrhage, Jaundice, Liver Disorder, Loss Of Consciousness, Renal Failure
on Jan 31, 2006 Female patient from JAPAN , 23 years of age, was diagnosed with dysmenorrhoea and was treated with Marvelon (View Usage). After Marvelon was administered, patient had the following side effects: haemodialysis, hepatic failure, hepatic haemorrhage, jaundice (What is jaundice?), liver disorder, loss of consciousness, renal failure. Marvelon dosage: Df, Oral. During the same period patient was treated with KAKKON (View Kakkon Review and Kakkon Label ).

4907484-0 | Haemodialysis, Hepatic Failure, Hepatic Haematoma, Loss Of Consciousness, Lymphadenopathy, Post Procedural Complication, Renal Failure
Patient was taking Marvelon (View Usage). Patient experienced the following unwanted or unexpected effects: haemodialysis, hepatic failure, hepatic haematoma, loss of consciousness, lymphadenopathy, post procedural complication, renal failure on Jan 11, 2006 from JAPAN Additional patient health information: Female patient , 23 years of age, was diagnosed with dysmenorrhoea and. Marvelon dosage: Df. During the same period patient was treated with KAKKON TO (View Kakkon-to Review and Kakkon-to Label ).

4906932-X | Hepatitis
Adverse event was reported on Jan 24, 2006 by a Female patient taking Marvelon (View Usage) (Dosage: Df) was diagnosed with menorrhagia and. Location: INDIA , 13 years of age, Patient had the following side effects: hepatitis (What is hepatitis?). Patient was hospitalized.

4875731-X | Pulmonary Infarction
on Dec 26, 2005 Female patient from JAPAN , 30 years of age, was treated with Marvelon (View Usage). After Marvelon was administered, patient had the following side effects: pulmonary infarction. Marvelon dosage: Df.